PJPvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with PJP, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PJP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PJP ETF 2 | +4.19%– | -1.35%– | -0.19%– | +32.41%– | +36.14%– | +36.99%– |
| Flows | PJP ETF 2 | -$60M– | -$51M– | +$29M– | +$35M– | -$45M– | -$93M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PJP ETF 2 | +18.80%– | +16.87%– | +15.61%– | +16.07%– |
| Max drawdown | PJP ETF 2 | -9.42%– | -9.42%– | -16.11%– | -17.41%– |
| Max drawdown duration | PJP ETF 2 | 75d– | 75d– | 275d– | 788d– |
Trading data
PJP | ETF 2 | |
Last sale 4/27/2026 at 1:30 PM | $103.80 | – |
| Previous close 04/24/2026 | $103.98 | – |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of March 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PJP | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 4/27/2026 at 1:30 PM
Live
Closed
PJP | ETF 2 | |
|---|---|---|
| Last price | $103.80 | – |
| 1D performance | -0.17% | – |
| AuM | $341.15 M | – |
| E/R | 0.57% | – |
Characteristics
PJP | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Invesco | – |
| Benchmark | Dynamic Pharmaceutical Intellidex Index | – |
| N° of holdings | 29 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
PJP
USA
94.75%
Other
5.25%
ETF 2
Sectors
PJP
Health Care
100%
Other
-0%
ETF 2
Advertisement
Diversification
PJP
Total weight of top 15 holdings out of 15
63.45%
ETF 2
–
Top 15 holdings
Data as of March 31, 2026
PJP
PFIZER
5.54%
JOHNSON&JOHNSON
5.43%
MERCK & CO INC
5.37%
ABBVIE
5.10%
AMGEN-T
5.07%
GILEAD SCIENCES
5.06%
ABBOTT LABS
5.05%
LILLY
4.69%
UTD THERAPEUT
3.40%
JAZZ PHARMACEUTICALS
3.24%
LIQUIDIA CORPORATION
3.22%
LIGAND PHARMACEUTICALS
3.19%
CORCEPT THERAPEUTICS
3.18%
INNOVIVA INC
2.98%
REGENERON PHARMACEUTICALS
2.94%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
